We’re delighted to share that the commitment to innovative health solutions by the German Federal Ministry of Education and Research (BMBF) remains strong. An additional grant of €490,000 has been allocated to sustain and advance the KMU-innovative: Biochance plus initiative Project23 . This grant extension, which runs until March 2024, will boost the ongoing development of InfectoTest® setting the stage for significant strides in accurate and sensitive malaria detection.
Continued Commitment: BMBF Invests Further in InfectoTest®
